🇺🇸 BICTEGRAVIR SODIUM in United States

65 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Drug Ineffective — 14 reports (21.54%)
  2. Off Label Use — 10 reports (15.38%)
  3. Diarrhoea — 6 reports (9.23%)
  4. Pathogen Resistance — 6 reports (9.23%)
  5. Toxicity To Various Agents — 6 reports (9.23%)
  6. Viral Mutation Identified — 6 reports (9.23%)
  7. Fatigue — 5 reports (7.69%)
  8. Drug Interaction — 4 reports (6.15%)
  9. Maternal Exposure During Pregnancy — 4 reports (6.15%)
  10. Pyrexia — 4 reports (6.15%)

Source database →

BICTEGRAVIR SODIUM in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is BICTEGRAVIR SODIUM approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for BICTEGRAVIR SODIUM in United States?

Marketing authorisation holder not available in our data.